Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2003
05/29/2003US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/28/2003EP1314734A1 Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313879A2 Methods for the survey and genetic analysis of populations
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313513A2 Identification, diagnosis, and treatment of breast cancer
05/28/2003EP0843739A4 Molecular combing of macromolecules through the action of a meniscus on hihgly specific surfaces
05/28/2003CN1420125A Trichina antigen gene Ts 87 and use thereof
05/28/2003CN1420124A DNA extracting method and use thereof in detecting transgene component in food
05/28/2003CN1420123A Nucleic acid sequence, method and kit for diagnosis of meningitis pathoogenic bacteria
05/27/2003US6570003 Human 7TM proteins and polynucleotides encoding the same
05/27/2003US6570001 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
05/27/2003US6570000 Nucleotide sequence coding monoclonal antibody for use in the treatment of viral diseases
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569643 Expression vector for use as tool in genetic engineering
05/27/2003US6569641 Which can modify transcription, replication or stability of a DNA sequence; producing stochastically generated polynucleotide sequences; expression vectors
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569620 By contacting them with the target molecule; separating and amplifying using SELEX process
05/27/2003US6569598 Photoresist films comprising aromatic polyamides that are stable and impervious to solvents used as barrier layers for preferential solid-phase synthesis with micron-scale resolution
05/27/2003US6569385 Fluid dispensing apparatus for a multiwell substrate; Serial and parallel dispensing tools that can deliver defined and controlled volumes of fluid to generate multi-element arrays of sample material on a substrate surface
05/27/2003US6569382 Electroosmotic movement and attachment of microscale and nanoscale devices
05/27/2003CA2199747C 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/27/2003CA2129442C Polyethylene or polypropylene glycol containing polymer
05/27/2003CA2123808C Improved electrochemiluminescent label for dna probe assays
05/27/2003CA2065424C Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobacteria infections and plasmides containing said fragments
05/22/2003WO2003042657A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
05/22/2003WO2003042401A2 Novel chromophores/fluorophores and methods for using the same
05/22/2003WO2003042364A2 Identifying and controlling the growth of estrogen-responsive cells
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003041659A2 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders
05/22/2003WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003WO2003003904A3 Coactivators in the diagnosis and treatment of breast cancer
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002097116A3 Delivery system for nucleic acids
05/22/2003WO2002044427A9 Cell based triple readout assay systems for identifying compounds that effect transcription
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030096987 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
05/22/2003US20030096986 Methods and computer software products for selecting nucleic acid probes
05/22/2003US20030096981 Nucleotide sequences for use in controlling gene expression
05/22/2003US20030096980 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/22/2003US20030096979 Oligonucleotides having A-DNA form and B-DNA form conformational geometry
05/22/2003US20030096970 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096967 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096965 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096964 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096963 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function
05/22/2003US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase)
05/22/2003US20030096776 Inhibiting the division of a malignant mammalian cell and for modulating the effects of cellular aging
05/22/2003US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096426 Forming microarray on surface of a substrate; provide vessel containing liquid in interior container, eject fluid onto surface of substrate, form array of sample
05/22/2003US20030096388 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096364 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096351 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096320 Oil bodies and associated proteins as affinity matrices
05/22/2003US20030096287 Oligonucleotide for use as diagnostic tool in genetic engineering
05/22/2003US20030096286 Oligoribonucleotides and ribonucleases for cleaving RNA
05/22/2003US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/22/2003US20030096273 Methods for immobilizing molecules to a solid phase and uses thereof
05/22/2003US20030096265 The formed probe for use in a microarray analysis to bond covalently to a hydrogel; solid phase synthsis
05/22/2003US20030096257 Solid support for use in the nucleotide sequence analysis
05/22/2003US20030096254 Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression
05/22/2003US20030096253 Single nucleotide amplification and detection by polymerase
05/22/2003US20030096252 Hybridization of preferential nucleotide sequence to target nucleic acid; obtain nucleic acid sample, incubate with detection probe, detect signal, presence of signal indicates presence of target nucleic acid
05/22/2003US20030096235 Complexity management of genomic DNA
05/22/2003US20030096234 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression
05/22/2003US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096229 Manipulating genetic material; obtain cells, disrupt, expose to column, label nucleotide sequences, elute labeled sequences
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095921 Administering a uridine analogue which is activated by thymidylate synthase to reduce or inhibit replication or spread of tumor cells; diagnosing tumors which are resistant to thymidylate synthase inhibitors
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003CA2465588A1 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1312674A1 Allosteric ribozymes and uses thereof
05/21/2003EP1311853A2 Combination of microporous membrane and solid support for microdiagnostics
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311681A2 Nucleic acids compositions conferring dwarfing phenotype
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311527A2 Novel strategie for synthesising polymers on surfaces
05/21/2003EP1311526A1 Processes for the preparation of oligonucleotides
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation